Oncology Expert Witnesses in Texas

Oncology, Hematology - cutaneous malignancies, gastrointestinal malignancies, melanoma, skin cancers, merkel cell, gastric, esophageal, liver, pancreas, colon, rectal, small bowel, neuroendocrine tumors, adenocarcinoma, soft tissue sarcoma, bone sarcoma, anal, abdominal, immunotherapy, chemotherapy

Samuel S. Thomas, MD Triple Board-Certified Medical Oncologist & Hematologist Windermere, Florida | Phone: (954) 663-7551 | Website: www.medoncmd.com Expert Witness Profile Dr. Sajeve Thomas is a triple board-certified (Internal Medicine, Hematology, Medical Oncology) medical oncologist with over 14 years of active clinical practice and more than 100 expert witness case reviews. He provides expert consultation for both plaintiff and defense in oncology-related malpractice claims, with specific expertise in cutaneous, gastrointestinal, and soft tissue malignancies. Dr. Thomas is known for his ability to clearly explain complex medical issues to juries, backed by balanced litigation experience, academic involvement, and ongoing clinical practice at a major cancer center. Areas of Expertise Delayed or missed cancer diagnosis Chemotherapy and immunotherapy complications Causation and prognosis in metastatic disease Standard of care reviews (SOC) Oncology adverse events & treatment dev...

Oncology, Hematology - Medical Malpractice, Failure to diagnose cancer, Improper cancer treatment, Product liability, Toxic Torts, Cancer causing agents, Patent Infringement

Dr. Stark has a blue-ribbon top-tier Ivy League education: BA cum laude from Yale and MD cum laude from Harvard. He trained in Internal Medicine at Washington University/Barnes Hospital and returned to Harvard for a fellowship in Medical Oncology at the Dana Farber Cancer Institute. He practiced Hematology and Medical Oncology for 34 years and is currently Full Professor of Medicine at Eastern Virginia Medical School and a visiting lecturer at the University of Miami. He is board-certified in Internal Medicine and Medical Oncology for life, is a Fellow of the American College of Physicians, and a member of the American Society of Clinical Oncology. He has extensive experience as a litigation expert serving plaintiffs and defendants in equal numbers throughout the United States. He is considered an expert testifying witness making a good impression with juries. He is an editor of Practical Reviews in Cancer Management, a publication of Oakstone Publications, which produces con...

Radiation Oncology, Oncology - Radiation injury, quality assurance, radiation safety, delayed diagnosis, breast cancer, radiation induced cancer, product liability, malpractice, radiation causation, mesothelioma, prostate cancer, causation, toxic tort, hospital safety, secondary cancer, latency, head neck cancer, radiation exposure, environmental exposure, cancer

https://www.cancercausationexpert.com pberonmd@gmail.com 310-709-4604 Board-certified radiation oncologist with more than 20 years of active clinical experience and longstanding expert witness experience in medical malpractice, radiation oncology standard of care, product liability, toxic tort, environmental exposure, radiation exposure, and radiation-induced cancer matters. Retained by both plaintiff and defense counsel. Expertise includes general and specific causation, radiation dose assessment, exposure pathway analysis, latency, tumor biology, competing risk factors, epidemiology, radiobiology, and mechanistic cancer causation. Frequently evaluates whether an alleged malignancy is medically and biologically consistent with the type, magnitude, dose, timing, and pathway of an alleged ionizing radiation or environmental exposure. Served as Chair of a national Radiation Oncology Quality Assurance Committee for the American Society for Radiation Oncology. Form...

Dallas, Texas

Orthopedic Surgery, Oncology - Revision joint arthroplasty, Orthopaedic infection, Implant failure, Standard of care orthopaedic s, Revision hip replacement, Orthopaedic oncology, Medical malpractice orthopaedic, Revision knee replacement, Sarcoma surgery, Products liability orthopedic, Prosthetic joint infection, Joint replacement failure, Limb salvage

Nathan F. Gilbert, MD, FAAOS is a board certified orthopaedic surgeon based in Dallas, Texas, with more than 15 years of active subspecialty practice in orthopaedic oncology and sarcoma surgery, complex reconstruction and revision joint arthroplasty, prosthetic joint infection, and orthopaedic infection management. He provides expert witness services to plaintiff and defense counsel nationally through Apex Orthopaedic Oncology and Complex Reconstruction Consulting. Dr. Gilbert trained at UT Southwestern Medical Center and completed his subspecialty fellowship in orthopaedic oncology at The University of Texas MD Anderson Cancer Center. He performs approximately 750 surgical cases annually, including approximately 400 revision joint arthroplasty procedures per year — among the highest volumes in the United States — and more than 200 prosthetic joint infection cases per year across all joint systems. He additionally performs approximately 200 orthopaedic oncology cases per year and is...

Austin, Texas

Oncology, Pharmaceutical Regulation - Oncology Drug Development, Patent Validity, ICH GCP, Written description, Enablement, Obviousness, Anticipation, Pharmacology, FDA, EMA, NMPA/China, PMDA/Japan, Drug formulation, Medical Safety, Phase 1-3 Clinical Trials, Drug Product Safety, Medical Oncology, Breach of Contract - Pharma/Biotech, Commercially Reasonable Efforts, Damages

Dr. Frederick (Fred) Hausheer is a physician-scientist with over 37 years of executive leadership and management experience in US and international (EU, JP, China, others) commercial pharmaceutical research and development (Phase I-III), preclinical translational and clinical medicine, clinical pharmacology, ICH GCP compliance and commercial development strategy and risk management of novel cancer therapeutics. His commercial research and development experience includes cytotoxic agents, targeted agents, immuno-oncology therapeutics, cell therapies (BMT, CAR-T), and supportive care medicines. He is an inventor/co-inventor on more than 400 issued United States and international pharmaceutical patents, and author/co-author of more than 200 scientific/medical publications. He is an experienced former CEO and Chief Medical Officer with several biopharma companies and a former NCI-Designated Clinical Investigator, NCI-Institutional Review Board voting member, and NCI-Experimental Ther...